Dutch Biotech plans Pivotal Clinical Trial with First Gene Therapy for Hemophilia – Labiotech.eu (blog)
|
Dutch Biotech plans Pivotal Clinical Trial with First Gene Therapy for Hemophilia
Labiotech.eu (blog) uniQure is getting ready to start a Phase III clinical trial in 2018 with a new version of its gene therapy for hemophilia B. uniQure has officially launched a plan to bring the first gene therapy for hemophilia to the market. After multiple meetings … |
